Kintor Pharmaceutical Limited

KNTPFOTCHealthcare● Active

$0.57

+$0.30(+110.58%)

Market Cap$265024496

P/E Ratio—

52W High$0.5708

52W Low$0.1774

Avg Volume256

Open$0.57

Beta-0.55

Overview

Kintor Pharmaceutical Limited (KNTPF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

KNTPF · earnings · updated Jun 10, 2026

Latest Earnings

Q1 FY2025Report Date: Mar 26, 2025

EPS Actual

-$0.00

Revenue

$0.00B

Fiscal Period

Q1 FY2025

FY ends December

Report Date

Mar 26, 2025

After Market Close

KNTPF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Next earnings date not yet announced.

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 31, 2026	—	—	—	—	—	—
◌ Q3 FY2025	Aug 28, 2025	—	—	—	—	—	—
— Q1 FY2025	Mar 26, 2025	—	-$0.00	—	$0.00B	—	—
◌ Q1 FY2025	Mar 26, 2025	—	—	—	—	—	—
— Q3 FY2024	Aug 26, 2024	—	-$0.02	—	—	—	—
— Q3 FY2024	Aug 26, 2024	—	-$0.02	—	$0.00B	—	—
◌ Q2 FY2024	Jun 20, 2024	—	—	—	—	—	—
◌ Q1 FY2024	Mar 28, 2024	—	—	—	—	—	—

Q3 FY2026

Aug 31, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 28, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 26, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2025

Mar 26, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 26, 2024

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 26, 2024

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2024

Jun 20, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Mar 28, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2025	Mar 26, 2025	—	$0.14	$0.15	+6.18%
— Q3 FY2024	Aug 26, 2024	—	$0.08	$0.08	+0.00%
— Q3 FY2024	Aug 26, 2024	—	$0.08	$0.08	+0.00%
— Q4 FY2023	Dec 31, 2023	—	$0.17	$0.17	+0.00%
— Q3 FY2023	Aug 28, 2023	—	$0.46	$0.46	+0.00%
— Q2 FY2023	Jun 30, 2023	—	$0.47	$0.47	+0.00%

Q1 FY2025+6.18%

Report Date

Mar 26, 2025

EPS Beat/Miss

—

Price Before

$0.14

Price After

$0.15

Q3 FY2024+0.00%

Report Date

Aug 26, 2024

EPS Beat/Miss

—

Price Before

$0.08

Price After

$0.08

Q3 FY2024+0.00%

Report Date

Aug 26, 2024

EPS Beat/Miss

—

Price Before

$0.08

Price After

$0.08

Q4 FY2023+0.00%

Report Date

Dec 31, 2023

EPS Beat/Miss

—

Price Before

$0.17

Price After

$0.17

Q3 FY2023+0.00%

Report Date

Aug 28, 2023

EPS Beat/Miss

—

Price Before

$0.46

Price After

$0.46

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$0.47

Price After

$0.47

Beat Rate0 / 6 quarters

Largest Move+6.18% (Q1 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Kintor Pharmaceutical Limited (KNTPF) most recently reported earnings on March 26, 2025 for Q1 FY2025, posting EPS of $-0.00 (in line with the analyst consensus of —).

Each quarter, investors track KNTPF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. KNTPF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

KNTPF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

KNTPF earnings · 4 questions

Kintor Pharmaceutical Limited's next earnings report is expected around TBD. KNTPF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; KNTPF historically reports after market close (AMC).

KNTPF earnings datewhen is KNTPF earningsKNTPF next earnings datewhen does KNTPF report earningsKNTPF earnings calendar

▸ Source: FMP · Kintor Pharmaceutical Limited SEC filings · US GAAP · Kintor Pharmaceutical Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026